A Federal Watchdog Said the Scheduling Process Has Gaps. Your Eighth Did Not Move.

A federal headline hit your phone Wednesday night: watchdog, scheduling gaps, marijuana. You glanced at the eighth in the cup holder and wondered if it just became federally fine. It didn't. The report is real, though, so before you change a single habit, here's what it actually said.

Did This Week's Federal Headlines Reschedule Your Eighth? #

No. A federal watchdog report about missing written procedures isn't a new schedule. Adult-use flower is still Schedule I. The April medical Schedule III rule is a different lane, and it doesn't cover a typical Detroit adult-use eighth.

Here's the week in one breath:

Date	What landed	What it did not do
Wed Sep 23, 2026	GAO-26-108623 said DEA and FDA have gaps in written scheduling policies	Move marijuana to a new schedule
Thu Sep 24, 2026	Law-firm recap of the still-open broader hearing (Morgan Lewis)	Issue a final adult-use Schedule III rule
Fri Sep 25, 2026	CANNRA op-ed: DEA HQ still has not sat with state regulators on the medical rule (Marijuana Moment)	Change Michigan adult-use possession or your jar's federal class

If you're a metro Detroit smoker on a smoke break, keep the jar rules you already knew. Michigan adult-use and Michigan medical are still two state programs under the Michigan Cannabis Regulatory Agency (CRA). Federal news didn't merge them this week.

For the long background on medical-only Schedule III, see Schedule III is here — but only for medical. For the full federal map, see our cannabis rescheduling Schedule 3 guide.

What Did the GAO Actually Publish on September 23? #

The U.S. Government Accountability Office published GAO-26-108623 on September 23, 2026: Drug Scheduling: While DEA Decisions Have Aligned with Recent HHS Recommendations, Both Need Comprehensive Policies. Public release went up the same day. Full PDF: gao-26-108623.pdf.

GAO is Congress's audit shop. It doesn't rewrite the Controlled Substances Act, and it doesn't flip a schedule with a report.

What GAO said without the jargon #

From the Highlights on the product page:

DEA does not have policies that identify roles, responsibilities, and procedures related to scheduling. FDA does not have policies or procedures specifying how its staff are to conduct evaluations or develop recommendations.

The Fast Facts on the same page say it plainer: both agencies could improve their scheduling policies. DEA lacks policies that identify roles, responsibilities, and procedures. FDA doesn't specify how staff should run evaluations or write recommendations.

What GAO measured (2020–2025) #

Fact from GAO	Number
Substances where DEA took scheduling actions	208
Cases where an HHS evaluation was required, and DEA considered it	95 of 95
Final rules that aligned with HHS (as of Dec 31, 2025)	84 of 84
Still under extended temporary scheduling orders	11

So the watchdog found alignment between DEA decisions and HHS advice wherever a final rule already existed. The knock is on missing written playbooks, not a failed marijuana vote last week.

Three recommendations (agencies agreed) #

Per GAO-26-108623:

1. DEA: write policies and procedures for how staff evaluate and schedule substances (admin scheduling, NDA scheduling, temporary scheduling, treaty scheduling, including three-factor and eight-factor work).
2. FDA: write how Center for Drug Evaluation and Research staff run eight-factor evaluations and recommendations, including how they judge "potential for abuse."
3. FDA and NIH: update a memorandum of understanding with NIDA that's over 40 years old.

Trade coverage that quotes those lines includes Marijuana Moment (Tom Angell, Sep 23) and Marijuana Herald. If you want the primary text, go to the gao.gov product page.

Is This a Marijuana Investigation or a Process Report? #

It's a process report about drug scheduling in general. Marijuana shows up as context and a topic tag, not as the single subject GAO investigated.

Read the Fast Facts opener on GAO-26-108623. The example risk drug is fentanyl, not flower. The study window is every DEA scheduling action from 2020 through 2025 — hundreds of substances, not one plant.

Why marijuana shows up in the coverage #

• Members of Congress asked how DEA weighs HHS science when it schedules drugs. GAO answered that question for all controlled-substance work in the window.
• The public is watching a separate, still-open marijuana rulemaking, and trade sites tied the two stories together. That's journalism context, not "GAO investigated weed and found it should move."
• The Highlights note rare scientific disagreements between DEA and FDA, then say the agencies usually talk it out before public comment. That's a process-culture note, not a schedule change for Michigan adult-use.

What a Detroiter should take from that #

If a headline said "federal watchdog" and "marijuana" in the same breath, ask: Did a schedule number change in the Code of Federal Regulations this week? For adult-use flower, no. The Michigan CRA still runs your state card and your adult-use purchase rules. A GAO audit of internal memos doesn't rewrite either one.

What Is Still True About Schedule I Adult-Use Flower? #

Adult-use marijuana that isn't covered by the April medical rule stays Schedule I under federal law. Your typical Detroit eighth from the adult-use counter didn't become federally Schedule III this week — or in April.

Schedule I is the federal bucket for substances the CSA treats as having high abuse potential and no currently accepted medical use under that statute's old frame. States can legalize adult-use, and federal criminal and civil tools still exist. That tension is old, and a GAO procedure report doesn't erase it.

Practical meaning for a Michigan shopper #

• State law still lets adults 21+ buy and possess under Michigan adult-use rules the CRA oversees.
• Federal class for that adult-use flower is still Schedule I unless and until a final broader rescheduling rule says otherwise.
• Crossing state lines, federal property, and federal employment policies still sit on the federal side of the ledger. Don't treat a news alert as a travel pass.

We already mapped the August picture for Michigan consumers in DEA rescheduling aftermath: what August 2026 means for Michigan. The September GAO story doesn't overturn that map. It adds a footnote about how agencies write their internal steps.

How Is the April 28 Medical Schedule III Rule a Different Lane? #

On April 28, 2026, the Federal Register published a final rule (91 FR 22714) that moved certain medical marijuana into Schedule III. That rule isn't the broader adult-use case, and it isn't this week's GAO report.

What the April rule covers (primary text) #

The Federal Register summary says the action applies to marijuana (and related CSA-defined material) to the extent it is:

1. included in an FDA-approved drug product, or
2. subject to a state-issued medical marijuana license for manufacture, distribution, and/or dispensing for medical purposes.

It also sets an expedited DEA registration path for entities that hold those state medical licenses. Effective date: April 28, 2026.

What it does not cover #

Lane	Federal picture after April 28, 2026
FDA-approved marijuana medicines	Schedule III under the final rule
State-licensed medical marijuana (qualifying license path)	Schedule III under the final rule
Typical adult-use / recreational flower sold outside that medical license frame	Still Schedule I unless a later final rule says otherwise

If you buy adult-use in Michigan with a regular 21+ ID and no patient card in play, you're not standing in the April medical lane. Michigan still runs both medical and adult-use programs through the CRA. The federal medical rule leans on state medical systems, and it doesn't rewrite Michigan adult-use into Schedule III by itself.

The deep dive on that medical lane is Schedule III medical-only — what happens next, and the full federal map is the cannabis rescheduling Schedule 3 guide.

What Are State Regulators Asking DEA About Right Now? #

On September 25, 2026, Gillian Schauer (executive director of the Cannabis Regulators Association, CANNRA) published an op-ed on Marijuana Moment arguing DEA headquarters still hasn't sat down with state officials to implement the April medical Schedule III rule.

That's a coordination story about the medical rule already on the books, not a new schedule for adult-use flower.

Who said what (named sources only) #

• Gillian Schauer / CANNRA: the state and territorial cannabis regulators' association. Nonpartisan implementers, not a lobby shop for "legalize everything," per the op-ed.
• Her claim: DEA HQ acknowledged the outreach but still hasn't met with CANNRA or convened states on the medical rule's open questions.
• Also her claim: some DEA field divisions do talk with states, but HQ hasn't set a consistent national sit-down.
• Open questions listed in the piece include dual medical/adult-use licenses, past convictions and registration, purchase-and-resale mechanics, caregiver purchases vs federal "patient only" warning-label language, and data requests that ignore how different state statutes work.

Where Michigan fits (without inventing a CRA quote) #

The Michigan CRA is a state cannabis regulator, so it sits in the same seat CANNRA is talking about: an agency already running licensed medical (and, in Michigan, adult-use) systems while federal desks rewrite forms. To be clear, the CRA didn't put out a press release about this, and we're not inventing one. If CANNRA's members need implementation answers, Michigan's regulator is in that class of agencies. That's still not the same as Lansing issuing a new consumer memo today.

If you're a Michigan patient or caregiver, the takeaway is patience and knowing your paperwork, not a free pass on adult-use jars. If you're an adult-use shopper, the CANNRA piece is background noise from a lane you're not in.

What About the Broader Rescheduling Hearing? #

A recommendation from an administrative law judge isn't a final rule. The broader marijuana Schedule III proposal is still open. Treat it as "if/when," never "done."

Morgan Lewis (Sep 24, 2026) recaps the timeline:

• Hearing testimony ran June 29 through July 15, 2026 (11 days) before Chief ALJ Derek C. Julius.
• Post-hearing briefs are filed.
• Next comes the ALJ's recommended decision, then exceptions, then the DEA Administrator makes the final agency call.

Until a final rule publishes and takes effect, adult-use marijuana outside the April medical lane stays where it was. We covered the hearing close in DEA rescheduling hearing ends July 2026.

How this differs from the GAO report #

Piece	Job
GAO-26-108623	Audit how DEA/FDA write internal scheduling procedures across many drugs
April medical final rule (91 FR 22714)	Already moved certain medical products/pathways to Schedule III
Broader hearing + future Administrator decision	May or may not move remaining marijuana; not finished

A Detroit shift worker who saw "rescheduling" and "watchdog" in the same feed should separate those three lines before changing a habit. Your medical card, if you have one, and your adult-use eighth, if that's what you buy, still live in two different federal stories.

GAO Gaps vs Medical III vs Open Adult-Use vs Your Week #

Four different stories. Don't mash them into one "weed is legal now" takeaway.

Story	What it is	Status as of Sep 25, 2026	What a Michigan shopper should do
GAO procedure gaps	GAO-26-108623: DEA/FDA lack written roles and how-to steps for scheduling work	Published Sep 23; recommendations open; agencies concurred	Read it as process reform, not a new schedule
April medical Schedule III	91 FR 22714: FDA-approved meds + qualifying state medical license path	Final rule effective Apr 28, 2026; CANNRA says HQ implementation talks still thin (op-ed)	Patients/operators follow medical rules; adult-use buyers do not claim this lane
Broader adult-use / remaining marijuana	Post-hearing ALJ path (Morgan Lewis)	Recommendation not issued as a final rule yet	Wait for a final Federal Register action; assume Schedule I until then
Your Michigan week	CRA adult-use vs medical; job policies; driving	Unchanged by the GAO headline	Buy legal, stay private, do not drive high, read your employer's policy

One-line cheat sheet #

• Watchdog report: missing SOPs inside agencies.
• Medical Schedule III: the April rule, medical lane only.
• Adult-use eighth: still Schedule I federally.
• ALJ hearing: the unfinished broader case.

That's the whole table. If a social post collapses those four rows into one victory lap, close the app.

What Should a Michigan Shopper Do This Week? #

Nothing dramatic. Keep shopping the state rules you already use, and don't rewrite your life around a GAO headline.

Checklist for metro Detroit this week #

1. Name the lane you're in. Adult-use with a 21+ ID, or medical with a patient card. The Michigan CRA runs both. The federal medical Schedule III rule only speaks to the medical side.
2. Ignore "your eighth is federally fine now" posts. That's not how the April rule or the GAO report work.
3. If you're medical, watch operators and the CRA for registration and label changes over months, not overnight. CANNRA's Sep 25 piece is about that unfinished coordination, not a consumer coupon.
4. If you're adult-use, your federal class didn't move this week. State legality in Michigan still isn't a federal free pass everywhere.
5. Keep receipts and COAs the way you already should. Process fights in D.C. don't replace a Michigan safety label.
6. Read primary docs when headlines scream. Start at GAO-26-108623 and the April Federal Register rule.

Divine Toke is Michigan sun-grown flower for people who already live under these rules. We're not a law firm. We're the jar, and we owe you a straight read.

What This Does Not Change for Your Job or Drug Test #

A GAO report about missing DEA/FDA memos doesn't rewrite your employer's handbook, a union CBA, or a roadside stop. Your job, your drug test, and the drive home didn't change this week because of Wednesday's watchdog story.

Employment #

Many metro Detroit workplaces (plants, hospitals, logistics, trades) still run THC drug screens. Federal Schedule I status for adult-use flower is one reason those policies stay sticky. Medical Schedule III may matter for some federal registration and tax fights on the business side, but it's not a guarantee your boss stops testing.

Driving #

Michigan adult-use law doesn't allow driving while impaired by cannabis, and a federal news cycle doesn't create a safe-to-drive carve-out. If you're high, don't drive. That sentence doesn't need a schedule table.

Travel and federal property #

Airports, federal buildings, and crossing state lines still sit under federal rules. Don't pack an eighth in a bag because a watchdog said agencies need better SOPs.

This section is education, not legal advice. For workplace or court questions, talk to a lawyer who practices in Michigan. For the plant science and shopping side, stick with what the label and the CRA already require.

FAQ #

Did the GAO reschedule marijuana on September 23, 2026? #

No. GAO-26-108623 is an audit of how DEA and FDA write scheduling procedures. It recommends better written policies. It doesn't publish a new schedule for marijuana.

Is adult-use flower still Schedule I federally? #

Yes, for typical adult-use product outside the April medical rule. The broader transfer to Schedule III is still unfinished after the June–July 2026 hearing (Morgan Lewis). Michigan adult-use legality under the CRA doesn't erase that federal class.

Does Michigan medical Schedule III cover a regular adult-use eighth? #

No. The April 28, 2026 final rule (91 FR 22714) covers FDA-approved marijuana medicines and marijuana under a qualifying state medical license path. A normal adult-use eighth is a different lane. See Schedule III medical-only.

What did GAO say DEA and FDA are missing? #

Written policies that spell out roles, responsibilities, and how staff run evaluations and recommendations. GAO's Highlights on gao.gov say DEA lacks those role/procedure policies, and FDA lacks procedures for how staff conduct evaluations or develop recommendations. FDA's NIDA MOU is also called out as over 40 years old.

Who is Gillian Schauer and what is CANNRA? #

Gillian Schauer is executive director of the Cannabis Regulators Association (CANNRA), a nonpartisan group of state and territorial cannabis regulators. Her September 25, 2026 Marijuana Moment op-ed says DEA headquarters hasn't meaningfully met with states/CANNRA on implementing the April medical Schedule III rule.

Did the Michigan CRA say anything new this week? #

This article doesn't invent a CRA quote. The Michigan CRA is Michigan's cannabis regulator. CANNRA speaks for state regulators as a class. Treat CRA as sitting in that same implementer seat. Schauer isn't speaking as the CRA.

Is the DEA ALJ recommendation a final Schedule III rule for adult-use? #

No. After the June 29–July 15, 2026 hearing, the ALJ issues a recommendation. Parties can file exceptions. The DEA Administrator decides the final agency action (Morgan Lewis). Until a final rule is in force, don't treat adult-use as federally Schedule III.

Does a watchdog report change my workplace drug test? #

No. Employer policies, CBAs, and testing vendors don't flip because GAO asked DEA to write better SOPs. Metro Detroit jobs that screen for THC still screen for THC until those policies change.

Where can I read the actual GAO report? #

Start here: product page https://www.gao.gov/products/gao-26-108623 and PDF https://www.gao.gov/assets/gao-26-108623.pdf. Recaps at Marijuana Moment and Marijuana Herald are secondary.

What should I read next on Divine Toke about Schedule III? #

Three existing explainers: Schedule III medical-only — what happens next, the cannabis rescheduling Schedule 3 guide, and DEA rescheduling aftermath for Michigan consumers. This news post is the Sep 23–25 week, not a rewrite of those pages.

Bottom Line for Detroit This Week #

Your eighth didn't move. Your medical card didn't magically become a federal adult-use pass. A watchdog said DEA and FDA need better written scheduling procedures. That's a real finding on gao.gov, and it's still not a new Controlled Substances Act schedule for the jar in your kitchen.

The week, stacked clean:

• Sep 23: GAO-26-108623 on procedure gaps.
• April 28 (still the medical rule): 91 FR 22714.
• Sep 25: CANNRA wants DEA HQ to talk to state regulators about implementing that medical rule (Schauer op-ed).
• Broader adult-use: still after the hearing, still waiting on a final decision (Morgan Lewis).

If you want sun-grown Michigan flower that already lived under these rules before the headline hit your phone, shop what you trust and read the label. Keep learning with Schedule III medical-only, the Schedule 3 guide, and the August Michigan aftermath.

This article is for educational purposes only and is not legal or medical advice. Cannabis laws and workplace policies change. Driving while impaired is illegal. Talk to a qualified professional about your situation.